Temporomandibular joint disorders
Conditions
Interventions
The objective of this clinical trial will be to investigate the change in the condylar position after the use of botulinum toxin, when infiltrated in masseter muscles, in patients with muscular TMD.
Biological/vaccine
Radiation
A12.207.152.846
Sponsors
Centro Universitário Hermínio Ometto - Uniararas
Centro Universitário Hermínio Ometto - Uniararas
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Female volunteers; aged 18 to 50 years old; at least 28 healthy dental elements; previously diagnosed with Muscular temporomandibular dysfunction according to the DC / TMD axis I; class I Angle classification; at least 4 of the six occlusion keys described by Andrews.
Exclusion criteria
Exclusion criteria: Class I and III of Angle classification patients, individuals undergoing orthodontic treatment, systemic diseases or pathologies associated with the stomatognathic system that are functional limitations, patients with posterior and / or anterior tooth loss.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to find a change in the most physiological condylar position, assessed by Cone Beam Computed Tomography 30 days after application of botulinum toxin.;Expected outcome 2: Evaluate the decrease in the level of pain in Temporomandibular Dysfunction using the VAS scale (Visual Analog Scale) 30 days after the application of botulinum toxin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactJulian Calegari
UNIARARAS
Outcome results
None listed